Evidence map›Paper›PMID 9096355›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1997

A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.

T Nouspikel, P Lalle, S A Leadon, P K Cooper, S G Clarkson

RetractedOpen access · greenAbstract readCase ReportsRetracted Publication
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. Review
  3. Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. The capacity of oocytes for DNA repair.Cellular and molecular life sciences : CMLS · 2018
    Review
  8. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Hypomorphic PCNA mutation underlies a human DNA repair disorder.The Journal of clinical investigation · 2014
    Article
  14. Article
  15. Mammalian transcription-coupled excision repair.Cold Spring Harbor perspectives in biology · 2013
    Review
  16. Oxidative DNA damage and nucleotide excision repair.Antioxidants & redox signaling · 2013
    Review
  17. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  18. Expression of XPG protein in human normal and tumor tissues.International journal of clinical and experimental pathology · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

T NouspikelDepartment of Genetics and Microbiology, University Medical Centre (CMU), Geneva 4, Switzerland.
P Lalle
S A Leadon
P K Cooper
S G Clarkson
Lawrence Berkeley National Laboratory · US

Funding

Mechanisms for Transcription-Coupled Repair in Human CellsR01CA063503 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI COOPER, PRISCILLA K. · 1994 to 2010
$3.9M
TRANSCRIPTION COUPLED REPAIR OF EUKARYOTIC CELLSR01CA040453 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI LEADON, STEVEN A · 1985 to 2002
$629k
NCI NIH HHS R01 CA040453NCI NIH HHS R01 CA063503
6 · The paper itself

Abstract

Xeroderma pigmentosum (XP) patients have defects in nucleotide excision repair (NER), the versatile repair pathway that removes UV-induced damage and other bulky DNA adducts. Patients with Cockayne syndrome (CS), another rare sun-sensitive disorder, are specifically defective in the preferential removal of damage from the transcribed strand of active genes, a process known as transcription-coupled repair. These two disorders are usually clinically and genetically distinct, but complementation analyses have assigned a few CS patients to the rare XP groups B, D, or G. The XPG gene encodes a structure-specific endonuclease that nicks damaged DNA 3' to the lesion during NER. Here we show that three XPG/CS patients had mutations that would produce severely truncated XPG proteins. In contrast, two sibling XPG patients without CS are able to make full-length XPG, but with a missense mutation that inactivates its function in NER. These results suggest that XPG/CS mutations abolish interactions required for a second important XPG function and that it is the loss of this second function that leads to the CS clinical phenotype.

Indexed as

MutationCells, CulturedChildCockayne SyndromeDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesFemaleFibroblastsHumansInfantMaleMolecular Sequence DataNuclear ProteinsTranscription FactorsUltraviolet RaysDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesNuclear ProteinsTranscription Factors

Identifiers

PMID9096355
PMCPMC20331
OpenAlexW2062582450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.